ResQ Pharma, Inc
ResQ Pharma, Inc
  • Home
  • About Us
  • Background
  • Target Indications
  • History
  • Contact
  • More
    • Home
    • About Us
    • Background
    • Target Indications
    • History
    • Contact
  • Home
  • About Us
  • Background
  • Target Indications
  • History
  • Contact

Advisory Board

Steven Shafer, MD

Olivier Visa, PharmD, MBA

Santhanam Suresh, MD

Scientific and Clinical Advisor

Dr. Shafer is currently a Professor of Anesthesiology at the Stanford University Medical Center and a Member of Stanford Medical Center’s IRB. He is the former Chair of FDA’s Anesthetic and Life Support Advisory  Committee.  

Santhanam Suresh, MD

Olivier Visa, PharmD, MBA

Santhanam Suresh, MD

 Scientific and Clinical Advisor 

Dr. Suresh is the current Chair of the Department of Anesthesiology at Ann & Robert H. Lurie Children’s Hospital of Chicago. He holds an MBA from Kellogg School of Business and is currently on the Boards of several key professional societies. 

Olivier Visa, PharmD, MBA

Olivier Visa, PharmD, MBA

Olivier Visa, PharmD, MBA

Commercialization Advisor

Dr. Visa is currently Vice President of OEM at RTI Surgical and the former Vice President of Global Compounding at Baxter. 

Antoinette Gawin, MSc

Antoinette Gawin, MSc

Olivier Visa, PharmD, MBA

Ms. Gawin is currently CEO of Terumo BCT. She is a former senior executive at Baxter International and GE Healthcare.

Todd Beck

Antoinette Gawin, MSc

Steve Bylina III, JD

Mr. Beck is the Founder and CEO of Beck Media & Marketing, based in Santa Monica, CA. Beck Media’s clients include Twitter, NBCUniversal, AmazonPrime, Hulu, and the Academy of Motion Picture Arts and Sciences.  

Steve Bylina III, JD

Antoinette Gawin, MSc

Steve Bylina III, JD

Mr. Bylina is currently Partner and President at the Commodities Company.  He is also Of Counsel at Ziliak Law, where he provides legal services to trading companies and their vendors.

Paul Hertz, MD

Francis Wisniewski

Francis Wisniewski

Dr. Hertz is a practicing anesthesiologist and a former Professor at the University of Illinois College of Medicine.

Francis Wisniewski

Francis Wisniewski

Francis Wisniewski

Mr. Wisniewski is the Managing Partner

of Hard 8 Venture Capital and the

Co-Founder and Managing Partner of

Hard Eight Futures. He is a Chicago-based serial entrepreneur and investor with extensive experience advising startups. 

  

LipidRescue® is an investigational drug; the safety and efficacy of the drug have not been approved or authorized by FDA. 

LipidRescue® is a proposed proprietary name that is subject to FDA approval. 


Website designed by JDW

Copyright © 2021 ResQ Pharma, Inc - All Rights Reserved.


Powered by GoDaddy